Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 05, 2022

BUY
$3.67 - $7.63 $2,565 - $5,333
699 Added 0.16%
427,070 $2.16 Million
Q4 2021

Feb 25, 2022

BUY
$4.98 - $10.0 $2.12 Million - $4.26 Million
426,371 New
426,371 $2.64 Million

Others Institutions Holding PEAR

About Pear Therapeutics, Inc.


  • Ticker PEAR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Health Information Services
  • Shares Outstandng 138,768,992
  • Market Cap $1.39M
  • Description
  • Pear Therapeutics, Inc., a commercial-stage healthcare company, develops and sells software-based medicines. Its commercial products are reSET for the treatment of substance use disorder related to alcohol, cannabis, cocaine, and stimulants; reSET-O for the treatment of opioid use disorder in combination with buprenorphine; and Somryst, a softwa...
More about PEAR
Track This Portfolio

Track Edbi Pte LTD Portfolio

Follow Edbi Pte LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Edbi Pte LTD, based on Form 13F filings with the SEC.

News

Stay updated on Edbi Pte LTD with notifications on news.